Novonesis AS

Transaction in Own Shares • Jun 1, 2012

June 1, 2012

On January 20, 2012, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.

Under the program Novozymes will buy back B shares for an amount of up to DKK 1,000 million in the period from January 20, 2012, to December 31, 2012.

The following transactions have been made under the program:

	Number of shares	Average purchase price	Transaction value, DKK
Accumulated, last announcement May 25, 2012 May 29, 2012 May 30, 2012 May 31, 2012	2,461,520 15,000 20,000 45,000 35,000	163.09 163.01 162.62 162.39	391,679,652 2,446,361 3,260,215 7,317,929 5,683,671
Accumulated under the program	2,576,520		410,387,828

Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 13,985 B shares in the period from May 25, to May 31, 2012. The shares related to these transactions were not part of the Safe Harbour share buyback program.

With the transactions stated above, Novozymes owns a total of 10,531,029 treasury shares, corresponding to 3.2% of the share capital. The total amount of shares in the company is 325,000,000 including treasury shares.

Contact persons:
Press and media:	Investor relations:
René Tronborg (Europe)	Martin Riise
Tel. (direct): +45 4446 2274	Tel. (direct): +45 4446 0738
Tel. (mobile): +45 3077 2274	Tel. (mobile): +45 3077 0738
Paige Donnelly (USA)	Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3209	Tel. (direct): +1 919 494 3483
Tel. (mobile): +1 919 218 4501	Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27